Critical

Neuromuscular blockade in the ICU

Paralysis · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Suxamethonium: depolarising, rapid/brief — intubation only; causes K⁺ efflux (dangerous hyperkalaemia in burns >24 h, denervation, immobility, myopathy). Non-depolarising: rocuronium (rapid, reversible with sugammadex), atracurium/cisatracurium (organ-independent Hofmann elimination — the ICU infusion choice), vecuronium/pancuronium (accumulate in organ failure).

Red flags

  • Suxamethonium in the burned/immobile/denervated patient can arrest them with hyperkalaemia
  • A paralysed patient with tears and tachycardia is AWAKE — deepen sedation immediately

Management

  • ICU indications are FEW: facilitating intubation, severe ARDS with ventilator dyssynchrony despite deep sedation (early, short course), refractory raised ICP surges, shivering control in TTM, tetanus/hyperthermia syndromes
  • NEVER paralyse without verified deep sedation — awareness under paralysis is a catastrophe; monitor depth (clinical ± BIS) and consider train-of-four
  • Eyes taped/lubricated, pressure-area care, DVT prophylaxis — the paralysed patient cannot protect anything
  • Stop daily and reassess: prolonged NMB (especially with steroids) drives ICU-acquired weakness
  • Residual block after boluses: reverse (sugammadex for rocuronium) and support until train-of-four recovers

Drugs & doses

Suxamethonium 1–1.5 mg/kg (avoid in hyperkalaemia risk states)
Rocuronium 1–1.2 mg/kg RSI; sugammadex 16 mg/kg for rescue reversal
Cisatracurium infusion for ventilated paralysis (e.g. 37.5 mg over 15 min then infusion in severe ARDS)
Atracurium — histamine release at high bolus doses

Paralysis is a last-resort tool with a sedation guarantee, an eye-care checklist and a daily stop.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.